Biocon will acquire all of Viatris’ convertible preferred equity in Biocon Biologics for $400 million in cash and $415 million in newly issued Biocon shares
Renalyx will continue operating as an independent unit within the group
The proposed transaction will be effected as a share swap
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Adcock Ingram has been a cornerstone of healthcare in South Africa, known for its trusted medication brands such as Panado, Myprodol, Epi-Max, Citro-soda and Allergex
BIL also holds an option to increase its equity stake by an additional 15%
Mansam, founded in 2022, is positioned as the first Arabian luxury fragrance brand with a vision for global expansion
PendraCare Group develops, manufactures and sells innovative cardiology catheter solutions and provides design, development and manufacturing services to other global OEM’s
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
Subscribe To Our Newsletter & Stay Updated
